ClinicalTrials.govpublic full text
A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
localized advanced or metastatic gastric adenocarcinoma or gastroesophageal junction adenocarcinoma, expressing human epidermal growth factor receptor-2 (her-2), disease progression after receiving at least one and at most two lines of systemic treatment in the past, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 836039
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.